Article detail · 2014 · article
A new era begins in risk communication regarding drug use in pregnancy: Changes in FDA pregnancy risk categories
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueTürkiye Aile Hekimliği Dergisi
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
Summary Twenty nine years after the introduction of Pregnancy Risk Categories, U.S. Food and Drug Administration (FDA) concluded that categories were not successful at conveying the possible risks of drug use in pregnancy. FDA announced its second generation approach to labeling drugs for use in pregnancy and lactation with the publication of Proposed Rule for Pregnancy and Lactation Labeling for Human Prescription Drug and Biological Products on May 29, 2008. The proposed rule is designed as a narrative text containing elements such as fetal risk summary, clinical considerations and data. This manuscript aims to increase information and awareness of family practitioners on this subject.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
13citationsOpenAlex · cited_by_count (cache / database)
10 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2021 Türkiye’de ve Dünyada Teratojenite Bilgi Servislerinin Çalışma Koşulları ve Sağladıkları HizmetlerCitations 3 · OpenAlex
- 2024 The embryotoxic and teratogenic effects of metamizole sodiumCitations 2 · OpenAlex
- 2024 Evaluation Of Maternal And Fetal Findings In Patients With Pemphigoid GestationisCitations 1 · OpenAlex
- 2022 Prenatal and Postnatal Consequences of Drug Exposure in PregnancyCitations 1 · OpenAlex
- 2022 Prenatal and Postnatal Consequences of Drug Exposure in PregnancyCitations 1 · OpenAlex
- 2026 Gebelerin Akılcı İlaç Kullanımına İlişkin Bilgi Düzeyleri ve Etkileyen Faktörlerin Belirlenmesi: Kesitsel Bir ÇalışmaCitations 0 · OpenAlex
- 2025 HAMİLELİK VE LAKTASYON DÖNEMİNDE RETİNOİK ASİT KULLANIMICitations 0 · OpenAlex
- 2024 Önemli Bir Sorun: Gebelikte Bilinçsizce İlaç KullanımıCitations 0 · OpenAlex
- 2020 Personal Preference and Experiences of Obstetrician and Gynaecolojists on Counselling About TeratogenityCitations 0 · OpenAlex
- 2020 Kadın doğum uzmanı hekimlerinin teratojenite danışmanlığı hakkındaki kişisel tercih ve tecrübeleriCitations 0 · OpenAlex